UPDATE 1-SAfrica picks up first cases of coronavirus variant from India · 16h ago
BRIEF-U.S. CDC Says Delivered 329,840,055 Doses Of Covid-19 Vaccine As Of May 8 Versus 327,124,625 Doses As Of May 7 · 19h ago
U.S. administers 257.3 mln doses of COVID-19 vaccines –CDC · 19h ago
UPDATE 1-Thailand set to boost COVID-19 vaccinations, expects to approve Moderna shots · 1d ago
Top 10 S&P 500 Stocks by Index Weight
These are the top 10 most heavily weighted stocks in the S&P 500 Index.
Investopedia · 1d ago
Ccm Investment Advisers Llc Buys Healthpeak Properties Inc, Applied Materials Inc, Johnson ...
GuruFocus News · 1d ago
Sanders Capital, LLC Buys Facebook Inc, Johnson & Johnson, Unilever PLC, Sells Verizon ...
GuruFocus News · 1d ago
AstraZeneca Weighs Seeking Full U.S. Approval for Covid Shot, Skipping Emergency-Use Application
The British drugmaker could skip asking the FDA for emergency-use authorization for its Covid-19 vaccine—and instead pursue the more time-intensive application for a full-fledged license to sell the shot.
The Wall Street Journal · 1d ago
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines · 1d ago
COVID-19 Vaccine Patent Polarizes The World: What You Need to Know
The COVID-19 pandemic is continuing to rage unabated. Just as countries across the globe were coming online from a protracted lockdown, the second and third wave of the pandemic is threatening to derail hopes of a return to a more normal way of life.  It's...
Benzinga · 1d ago
EMA Safety Committee Reviews Heart Inflammation, Rare Nerve Disorder Reports After Pfizer, AstraZeneca COVID-19 Shots
European Medical Agency (EMA) is reviewing reports of a rare nerve-degenerating disorder in people who received AstraZeneca P
Benzinga · 1d ago
Pfizer CEO opposes U.S. call to waive Covid vaccine patents, cites manufacturing and safety issues
Pfizer's CEO said the waiver proposal "will unleash a scramble for the critical inputs we require in order to make a safe and effective vaccine.' · 1d ago
DJ Publix Offering Walk-In Vaccinations -- Market Talk
Dow Jones · 1d ago
Covid cases are falling in 30 states with a third of Americans fully vaccinated
The rate of daily Covid infections is declining in 30 states and the District of Columbia and one-in-three Americans are now fully vaccinated. · 1d ago
U.S. Support for Patent Waiver Unlikely to Cost Covid-19 Vaccine Makers in Short Term
The Biden administration’s move doesn’t affect vaccine makers’ deals to supply billions of dollars in doses, but could have longer-term consequences. · 1d ago
DJ WHO Endorses China's Covid-19 Vaccine Sinopharm--4th Update
Dow Jones · 1d ago
UPDATE 4-WHO approves Sinopharm vaccine in potential boost to COVAX pipeline · 1d ago
UPDATE 3-Sinopharm vaccine gets WHO nod in potential boost to COVAX pipeline · 1d ago
WHO chief urges world to follow U.S. lead and support waiving Covid vaccine patent protections
WHO chief says he urges other countries to follow the example of the U.S. on supporting vaccine patent waivers. · 1d ago
One out of three Americans fully vaccinated for COVID-19, CDC says · 1d ago
Webull provides a variety of real-time JNJ stock news. You can receive the latest news about Johnson&Johnson through multiple platforms. This information may help you make smarter investment decisions.
About JNJ
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.